For research use only. Not for therapeutic Use.
BT200 sodium (Cat No.: I040108) is a chemical compound under investigation for its potential therapeutic properties, particularly in the field of oncology and immunotherapy. It is often studied for its ability to modulate specific biological pathways, such as immune cell activation or cancer cell proliferation. BT200 sodium may work by targeting particular receptors or enzymes involved in tumor growth or immune regulation, offering a novel approach to cancer treatment. Further research is required to fully understand its efficacy and safety in clinical applications.
| Purity | ≥95% |
| Reference | [1]. Zhu S, Gilbert JC, Liang Z, et al. Potent and rapid reversal of the von Willebrand factor inhibitor aptamer BT200. J Thromb Haemost. 2020;18(7):1695-1704. [2]. Zhu S, Gilbert JC, Hatala P, et al. The development and characterization of a long acting anti-thrombotic von Willebrand factor (VWF) aptamer. J Thromb Haemost. 2020;18(5):1113-1123. |
